AzTrials
AzTrials

Pelvic Floor DisorderNCT06689891

Video-Based Pelvic Floor Muscle Therapy

A study testing Pelvic Floor Muscle Therapy Website in people with Pelvic Floor Disorder and Pelvic Floor Muscle Exercise, run by Yale University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a feasibility, pilot trial of remote, video-based pelvic floor muscle therapy (PFMT) for patients with pelvic floor disorders, including pelvic organ prolapse, urinary incontinence and anorectal dysfunction. PFMT has been shown to improve these symptoms in multiple studies. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Pelvic Floor Muscle Therapy Website
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
9 Jun 2025to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of pelvic floor dysfunction with referral for PFR
  • English-speaking

Who cannot join

  • Unable to access web-based videos
  • Unable to speak English

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anne Mongiu, MD, PhD contact

203-785-2616

Anne.mongiu@yale.edu

Samantha Linhares, MD contact

203-843-6140

Samantha.linhares@yale.edu

United States1 site, 1 recruiting
  • Yale New Haven Hospital

    New Haven, Connecticut, 06520

    Recruiting

Other trials in United States

About this study

Official title: Utilizing Remote, Video-Based Pelvic Floor Muscle Therapy: A Feasibility Trial

This study is a feasibility, pilot trial of remote, video-based pelvic floor muscle therapy (PFMT) for patients with pelvic floor disorders, including pelvic organ prolapse, urinary incontinence and anorectal dysfunction. PFMT has been shown to improve these symptoms in multiple studies.

Read the detailed description

This will be a feasibility and acceptability trial of a novel remote, web-accessible PFMT curriculum, designed by pelvic floor physical therapists.

Patients will be expected to complete a 5-10-minute survey at initial enrollment. They will have one in-person session with a pelvic floor therapist prior to starting the 8-week video-based PFMT course. Afterwards, they will have a final in person session with a pelvic floor therapist along with a final set of surveys that should take an estimated 10-15 minutes.

The primary objective is to the determine the feasibility and accessibility of using a video-based PFMT for patients with pelvic floor dysfunction.

The secondary objective is to determine whether video-based PFMT can improve symptomatology and quality of life.

Being tested
Pelvic Floor Muscle Therapy Website
Medical subject headings
Pelvic Floor Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pelvic Floor Muscle Therapy WebsiteDevice

    8-week video-based, self-directed PFMT course

Study groups in NCT06689891
Study groupRoleWhat they receive
Video-based pelvic floor muscle therapy (PFMT)ExperimentalPatients will complete a series of surveys before and after the intervention. They will complete 8 weeks of video-based PFMT with an initial and final in-person session with a pelvic floor therapist.
Receives: Device: Pelvic Floor Muscle Therapy Website

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. System Usability Scale (SUS) Score

    The SUS is a 10-question survey that measures how easy a product or system is to use. Total score range from 0-100 with higher scores indicating better usability.

    Measured: 8 weeks

  2. Percentage of participants video completion

    Percentage of participants that complete at least 80% of the videos

    Measured: 8 weeks

  3. Change in graded evaluation of exercises by pelvic floor therapist

    Participants will be assessed and graded and by the pelvic floor physical therapist as below: 1 - cannot perform exercise, 2 - can partially perform exercise (needs some cueing and assistance), 3 - can independently perform exercise

    Measured: baseline and 8 weeks

  4. Adverse Events

    Number of participants that experience at least one adverse event.

    Measured: up to 8 weeks

Secondary outcomes (5)
  1. Short Form-12 (SF-12)

    The SF-12 is an abbreviated version of the SF-36. The SF-12 is a validated survey that assesses a patient's health related quality of life across eight domains. The total score range is 0-100 with a physical component summary and a mental component summary. A higher score indicates better health for each of those components.

    Measured: baseline and week 9

  2. Cleveland Clinic Incontinence Score (CCIS)

    The CCIS is a health-related quality of life measure that assesses how often and to what degree incontinence affects a person's life. The total score ranges from 0 to 20, with higher scores indicating higher levels of incontinence.

    Measured: baseline and week 9

  3. Patient Assessment of Constipation Symptoms (PAC-SYM)

    The PAC-SYM is a questionnaire used to assess the severity of constipation symptoms in adults. Total score range 0-4 with higher scores indicating more severe constipation.

    Measured: baseline and week 9

  4. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)

    The ICIQ-SF is a brief patient-completed questionnaire that measures the impact of urinary incontinence (UI) on quality of life (QoL). The ICIQ-UI SF is scored on a scale of 0-21. A score of zero means no urine leakage and no impact on QoL.

    Measured: baseline and week 9

  5. Pelvic Organ Prolapse Symptom Score (POP-SS)

    The POP-SS is a questionnaire that measures the severity of pelvic organ prolapse symptoms. The total score ranges from 0-28, with higher scores indicating more severe symptoms.

    Measured: baseline and week 9

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2024
  2. Study start9 Jun 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Model description
Study population will include patients who have an indication for referral for pelvic floor rehabilitation (PFR).
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06689891
Sponsor's protocol ID
2000037163
Status last verified
Jan 2026
First submitted
13 Nov 2024
Last updated
16 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pelvic Floor Muscle Therapy Website in people with Pelvic Floor Disorder and Pelvic Floor Muscle Exercise, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anne Mongiu, MD, PhD (203-785-2616, Anne.mongiu@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

System Usability Scale (SUS) Score (time frame: 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in